Bed Bath & Beyond Inc. (NASDAQ:BBBY) was downgraded by Wolfe Research from a “market perform” rating to an “underperform” rating in a research note issued on Monday, The Fly reports.

A number of other analysts have also recently commented on BBBY. Zacks Investment Research raised shares of Bed Bath & Beyond from a “sell” rating to a “hold” rating in a research note on Wednesday, March 15th. Loop Capital reissued a “sell” rating and set a $35.00 target price on shares of Bed Bath & Beyond in a research note on Thursday, March 30th. Telsey Advisory Group cut their target price on shares of Bed Bath & Beyond from $42.00 to $41.00 and set a “market perform” rating for the company in a research note on Thursday, April 6th. Wedbush cut their target price on shares of Bed Bath & Beyond from $42.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday, April 6th. Finally, Oppenheimer Holdings, Inc. restated a “hold” rating on shares of Bed Bath & Beyond in a research report on Thursday, April 6th. Eight analysts have rated the stock with a sell rating, fifteen have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $42.87.

Analyst Recommendations for Bed Bath & Beyond (NASDAQ:BBBY)

Bed Bath & Beyond (NASDAQ:BBBY) traded down 0.93% on Monday, hitting $35.00. 905,922 shares of the company’s stock traded hands. Bed Bath & Beyond has a one year low of $33.63 and a one year high of $48.83. The stock has a 50-day moving average of $35.87 and a 200-day moving average of $39.74. The stock has a market cap of $5.00 billion, a PE ratio of 7.64 and a beta of 1.01.

Bed Bath & Beyond (NASDAQ:BBBY) last released its earnings results on Wednesday, April 5th. The retailer reported $1.84 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.07. The business had revenue of $3.53 billion during the quarter, compared to analysts’ expectations of $3.50 billion. Bed Bath & Beyond had a net margin of 5.61% and a return on equity of 26.26%. The company’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.91 earnings per share. On average, equities analysts forecast that Bed Bath & Beyond will post $4.32 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 18th. Stockholders of record on Friday, June 16th will be issued a $0.15 dividend. This is a positive change from Bed Bath & Beyond’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 1.70%. The ex-dividend date of this dividend is Wednesday, June 14th. Bed Bath & Beyond’s dividend payout ratio is currently 13.04%.

WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/06/19/bed-bath-beyond-inc-bbby-downgraded-by-wolfe-research.html.

In other news, insider Arthur Stark sold 8,933 shares of the company’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $39.73, for a total value of $354,908.09. Following the transaction, the insider now directly owns 149,595 shares in the company, valued at approximately $5,943,409.35. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Steven H. Temares sold 200,000 shares of the company’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $39.83, for a total transaction of $7,966,000.00. Following the completion of the transaction, the chief executive officer now owns 603,515 shares in the company, valued at $24,038,002.45. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 349,706 shares of company stock worth $13,679,409. Company insiders own 5.00% of the company’s stock.

Several institutional investors have recently modified their holdings of BBBY. Nicholas Hoffman & Company LLC. raised its position in shares of Bed Bath & Beyond by 0.4% in the first quarter. Nicholas Hoffman & Company LLC. now owns 7,930 shares of the retailer’s stock valued at $313,000 after buying an additional 28 shares in the last quarter. Amalgamated Bank raised its position in shares of Bed Bath & Beyond by 0.3% in the first quarter. Amalgamated Bank now owns 10,575 shares of the retailer’s stock valued at $417,000 after buying an additional 32 shares in the last quarter. Nordea Investment Management AB raised its position in shares of Bed Bath & Beyond by 1.7% in the first quarter. Nordea Investment Management AB now owns 7,704 shares of the retailer’s stock valued at $304,000 after buying an additional 129 shares in the last quarter. Blair William & Co. IL raised its position in shares of Bed Bath & Beyond by 1.5% in the first quarter. Blair William & Co. IL now owns 14,012 shares of the retailer’s stock valued at $566,000 after buying an additional 213 shares in the last quarter. Finally, ARGI Investment Services LLC raised its position in shares of Bed Bath & Beyond by 1.1% in the first quarter. ARGI Investment Services LLC now owns 27,289 shares of the retailer’s stock valued at $1,076,000 after buying an additional 284 shares in the last quarter. Hedge funds and other institutional investors own 92.45% of the company’s stock.

Bed Bath & Beyond Company Profile

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

The Fly

Receive News & Ratings for Bed Bath & Beyond Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond Inc. and related companies with MarketBeat.com's FREE daily email newsletter.